“The Future of Oncology Therapeutics – Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline as well as Deals Analysis”, this inform is an necessary source of interpretation as well as investigate upon a cancer marketplace in a tip 7 markets of a world. It covers a marketplace landscape, pass marketplace trends, marketplace drivers as well as restraints. The inform additionally identifies pass diagnosis use patterns opposite 7 vital markets namely, a US, EU5 as well as Japan. In addition, it brings out a existent rival landscape of a oncology therapeutics market, characteristics of a tip 5 marketplace indicators, as well as mergers as well as acquisitions that have taken place involving cancer therapies over a final a single year. ( http://www.bharatbook.com/detail.asp?id=126920&rt=The-Future-of-Oncology-Therapeutics-Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html )
The Global Oncology Therapeutics Market is Forecast to Grow during More Than a Overall Pharmaceutical Industry Growth Rate
The tellurian oncology therapeutics marketplace was valued during $48.1 billion in 2008. The expansion in a marketplace is essentially driven by a fast uptake of aim therapies as well as code brand new developments that have come to provide a niche segments such as renal dungeon carcinoma, liver cancer as well as go through cancers with tall unmet needs. However, a expansion of a marketplace is approaching to delayed down marginally due to a liquid of most “me too” versions of determined therapies. In annoy of this, a tellurian cancer therapeutics marketplace is approaching to grow during a Compound Annual Growth Rate (CAGR) of 10.9% in in in in in between 2008 as well as 2015.
The US, with an Approximate Market Share of 55.1% in 2008, was a Leading Market in a Global Cancer Therapeutics market
In 2008, a oncology therapeutics marketplace in a US was estimated during we estimate $26.5 billion, indicating a CAGR of 16.3% in in in in in between 2000 as well as 2008. However, in expectation of code brand new healthcare regulations, a marketplace is approaching to delayed down to 11% in in in in in between 2008 as well as 2015 as well as jot down sales value of $55.1 billion by 2015. Similarly, in 2008, a oncology therapeutics marketplace in a EU5 countries was estimated during we estimate $15.5 billion, indicating a CAGR of 15.7% in in in in in between 2000 as well as 2008. Oncology therapeutics marketplace in Japan was estimated during we estimate $6.1 billion, indicating a CAGR of 15.6% in in in in in between 2000 as well as 2008.
Breast Cancer Therapeutic Indication was a Leading Therapy Market with an Estimated Market Share of 16% of a Global Oncology Therapeutics Market
In 2008, a tip 5 cancer healing indications accounted for we estimate 58.1% of a tellurian oncology therapeutics market. Breast cancer was a heading healing denote with an estimated marketplace share of 16.5%, followed by Non-Hodgkin’s lymphoma (NHL) as well as colorectal cancer (CRC) that accounted for an estimate marketplace share of 12.8% as well as 11.4%, respectively. Prostate cancer therapeutics market, with an estimated marketplace share of 10.5%, was a subsequent heading healing indicator, followed by lung cancer.
Roche/Genentech, Novartis as well as Sanofi-Aventis have been a Top Three Players Operating in a Global Oncology Market
In 2008, a tip 10 companies in a oncology therapeutics marketplace accounted for 82.3% of a tellurian oncology therapeutics market. Rituxan was a heading cancer care code with an estimate sales value of $5.5 billion, followed by Avastin, that available sales of $4.8 billion as well as Herceptin, that purebred net sales value $4.7 billion. The tip 3 companies namely, Roche/Genentech, Novartis as well as Sanofi-Aventis, accounted for we estimate 50% of a tellurian oncology therapeutics marketplace in 2008.
To know some-more as well as to buy a duplicate of your inform feel giveaway to revisit : http://www.bharatbook.com/detail.asp?id=126920&rt=The-Future-of-Oncology-Therapeutics-Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html
Or
Contact us during :
Bharat Book Bureau
Tel: +91 twenty-two 27578668
Fax: +91 twenty-two 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us upon twitter: http://twitter.com/3bbharatbook
We have been a heading report aggregator, facilitates as well as supports a commercial operation report needs. With over 115,000 reports, we can get present entrance as well as insights upon a studies in yo for marketplace investigate , corporate / vital formulation by upon condition that a ultimate report in a form of reports, journals, magazines as well as databases upon sundry industries similar to automotive, oil as well as gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, nation intelligence, consumer & permanent goods, containing alkali as well as some-more ur areas of interest. Contact us during +91 twenty-two 27578668 / 27579438 or email info@bharatbook.com or the website www.bharatbook.com
Article Source: